Debendra Nath Roy

Hypertension (HTN) is the most common chronic condition dealt with primary care physicians and other health practitioners and is arguably the most important modifiable risk factor for coronary heart disease and stroke. The aim of our current study was designed to evaluate the prevalence of hypertension on age it is more prone to be started now a day, alongside the spectrum of HTN in respect with gender categorization. This study was carried out in the cardiology clinics as well as government hospitals and others at four cities in Bangladesh. From this survey the outcome was found that 39% of 45-60 years and 27% of 35-45 years aged was hypertensive patient, of which 54.83% were male and 45.17% were female. However, HTN control rates of patients cared for longitudinally by cardiologist, it was observed that beta blocker was present in 45% mono therapy prescriptions, among which only propranolol was for 34% cases and losartan was 20% at second. Combination therapy was also found to prescribe where olmesartan plus atenolol was 19% and amlodipine plus atenolol was prescribed for 17% of hypertensive patients. 

This work was carried out to investigate the lipid profile level in ethyl acetate extract of Ganoderma lucidum and atorvastatin in normal and alloxan induced diabetic mice.  Ganoderma lucidum and atorvastatin have shown to reduce LDL level 10.4 and 14.59%, TC level 06.76 and 09.78%, TG level 07.40 and 09.82% alongside equipotently increased HDL level to 09.33 and 15.18% respectively in normal mice. However, in case of diabetic mice, these values were 11.61 and 14.46% for LDL, 10.56 and 13.00% for TC, 10.38 and 13.96% for TG, 14.94 and 20.02% for HDL as well. Therefore, these results suggested that, intra peritoneal administration of Ganoderma lucidum have significantly (p